|
시장보고서
상품코드
2008878
생체흡수성 스텐트 시장 보고서 : 바이오소재별, 흡수율별, 용도별, 최종사용자별, 지역별(2026-2034년)Bioabsorbable Stents Market Report by Biomaterial, Absorption Rate, Application, End User, and Region 2026-2034 |
||||||
세계의 생체흡수성 스텐트 시장 규모는 2025년에 4억 6,750만 달러에 달했습니다. 향후에 대해 IMARC Group은 2034년까지 시장 규모가 8억 1,590만 달러에 달하며, 2026-2034년에 CAGR 6.19%로 성장할 것으로 예측하고 있습니다.
생체흡수성 스텐트(BRS)는 항증식제 또는 유전자가 코팅되어 있으며, 시간이 지남에 따라 용해되어 혈관의 개통성을 회복하고, 리코일을 유지하면서 리모델링을 가능하게 합니다. 이를 통해 분지점의 혈류를 조절하고 저관류 상태를 유지하면서 혈관 네트워크의 특정 영역으로의 혈류량을 제한하는 데 도움이 됩니다. 또한 심장 컴퓨터단층촬영(CT)이나 자기공명영상(MRI)을 통한 병변의 영상 진단의 정확도를 높입니다. 또한 스텐트 구조물을 남기지 않아 혈관 자극과 염증을 감소시켜 동일 부위의 재시술을 용이하게 합니다. 그 결과, BRS는 전 세계 병원과 심장센터에서 폭넓게 활용되고 있습니다.
생체흡수성 스텐트 시장 동향:
건강에 해로운 식습관, 운동 부족, 담배와 알코올 과다 섭취로 인한 심혈관 질환의 유병률 증가는 시장을 주도하는 요인 중 하나입니다. 또한 막힌 동맥을 뚫어 체내에 산소가 풍부한 혈액을 공급하기 위해 경피적 관상동맥중재술(PCI) 시술의 이용이 증가하고 있습니다. 이는 확대되는 의료 산업과 맞물려 시장 성장에 기여하고 있습니다. 이와 더불어, 생체흡수성 스텐트의 장점에 대한 대중의 인식이 높아짐에 따라 업계 투자자들에게 매력적인 성장 기회를 제공하고 있습니다. 또한 수술 후 통증이 적고, 수술 중 및 수술 후 합병증이 적으며, 입원 기간이 짧고, 회복이 빠르다는 이유로 최소침습수술에 대한 수요가 증가하고 있으며, 이는 시장에 긍정적인 영향을 미치고 있습니다. 이와는 별도로, 주요 시장 기업은 관상동맥 질환 치료를 위한 'SLENDER' 통합 전달 시스템(IDS) 고정 와이어와 'DIRECT RX' 생체흡수성 급속 교체형 약제용출 스텐트(DES) 시스템을 도입하기 위해 연구개발(R&D) 활동에 많은 투자를 하고 있습니다. 투자하고 있습니다. 또한 폴리머 기반 스텐트 개발에도 주력하고 있으며, 이는 시장 성장을 촉진할 것으로 예상됩니다.
목차
제1장 서문
제2장 조사 범위와 조사 방법
제3장 개요
제4장 서론
제5장 세계의 생체흡수성 스텐트 시장
제6장 시장 내역 : 바이오소재별
제7장 시장 내역 : 흡수율별
제8장 시장 내역 : 용도별
제9장 시장 내역 : 최종사용자별
제10장 시장 내역 : 지역별
제11장 SWOT 분석
제12장 밸류체인 분석
제13장 Porter's Five Forces 분석
제14장 가격 분석
제15장 경쟁 구도
KSA 26.05.13The global bioabsorbable stents market size reached USD 467.5 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 815.9 Million by 2034, exhibiting a growth rate (CAGR) of 6.19% during 2026-2034.
Bioabsorbable stents (BRS) are coated with an antiproliferative drug or gene that dissolves over time to restore vessel patency and permit remodeling while retaining recoil. It helps in regulating blood flow at branch points and limiting the amount of blood to areas of the vascular network while maintaining the flow at low perfusion. It also improves lesion imaging with cardiac computed tomography (CT) and magnetic resonance imaging (MRI). In addition, it leaves no residual scaffold, reduces vessel irritation and inflammation, and facilitates repeat treatments to the same site. As a result, BRS finds extensive applications in hospitals and cardiac centers across the globe.
BIOABSORBABLE STENTS MARKET TRENDS:
The growing prevalence of cardiovascular diseases due to an unhealthy diet, physical inactivity, and excessive consumption of tobacco and alcohol represents one of the factors driving the market. Moreover, there is a rise in the utilization of percutaneous coronary intervention (PCI) procedures to open a blocked artery for carrying oxygen-rich blood through the body. This, along with the expanding healthcare industry, is contributing to the growth of the market. Besides this, the increasing awareness among the masses about the benefits of bioabsorbable stents is offering lucrative growth opportunities to industry investors. In addition, the growing demand for minimally invasive procedures due to less postoperative pain, fewer operative and postoperative complications, shortened hospital stay, and faster recovery times is positively influencing the market. Apart from this, key market players are extensively investing in research and development (R&D) activities to introduce SLENDER integrated delivery system (IDS) fixed-wire and DIRECT RX bioabsorbable rapid-exchange drug-eluting stent (DES) systems to treat coronary artery disease. They are also focusing on developing polymer-based stents, which is expected to bolster the growth of the market.
KEY MARKET SEGMENTATION:
Breakup by Biomaterial:
- Polymer-based Bioabsorbable Stents
- Metal-based Bioabsorbable Stents
Breakup by Absorption Rate:
- Slow-Absorption Stents
- Fast-Absorption Stents
Breakup by Application:
- Coronary Artery Disease
- Peripheral Artery Disease
Breakup by End User:
- Hospitals
- Cardiac Centers
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
COMPETITIVE LANDSCAPE:
The report provides a comprehensive analysis of the competitive landscape in the global bioabsorbable stents market with detailed profiles of all major companies, including:
- Arterius Limited
- B. Braun SE
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Elixir Medical
- Kyoto Medical Planning Co., Ltd.
- Lepu Medical Technology (Beijing) Co., Ltd.
- Meril Life Sciences
- Reva Medical, LLC
- Terumo Corporation
KEY QUESTIONS ANSWERED IN THIS REPORT
1. What was the size of the global bioabsorbable stents market in 2025?
2. What is the expected growth rate of the global bioabsorbable stents market during 2026-2034?
3. What are the key factors driving the global bioabsorbable stents market?
4. What has been the impact of COVID-19 on the global bioabsorbable stents market?
5. What is the breakup of the global bioabsorbable stents market based on the biomaterial?
6. What is the breakup of the global bioabsorbable stents market based on the absorption rate?
7. What is the breakup of the global bioabsorbable stents market based on the application?
8. What is the breakup of the global bioabsorbable stents market based on the end user?
9. What are the key regions in the global bioabsorbable stents market?
10. Who are the key players/companies in the global bioabsorbable stents market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Bioabsorbable Stents Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Biomaterial
- 6.1 Polymer-based Bioabsorbable Stents
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Metal-based Bioabsorbable Stents
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Absorption Rate
- 7.1 Slow-Absorption Stents
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Fast-Absorption Stents
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Application
- 8.1 Coronary Artery Disease
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Peripheral Artery Disease
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Cardiac Centers
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Arterius Limited
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.2 B. Braun SE
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 Financials
- 15.3.2.4 SWOT Analysis
- 15.3.3 Biotronik SE & Co. KG
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 SWOT Analysis
- 15.3.4 Boston Scientific Corporation
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Elixir Medical
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 Kyoto Medical Planning Co., Ltd.
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Lepu Medical Technology (Beijing) Co., Ltd.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.7.3 Financials
- 15.3.8 Meril Life Sciences
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 Reva Medical, LLC
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.10 Terumo Corporation
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.1 Arterius Limited
